HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer

A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts...